Serum Procalcitonin for Predicting the Failure of Conservative Management and the Need for Bowel Resection in Patients with Small Bowel Obstruction

被引:50
|
作者
Cosse, Cyril [1 ,2 ]
Regimbeau, Jean Marc [1 ,3 ]
Fuks, David [1 ,2 ]
Mauvais, Francois [4 ]
Scotte, Michel [5 ]
机构
[1] Jules Verne Univ Picardie, Dept Digest & Metab Surg, Amiens Univ Hosp, Amiens, France
[2] Jules Verne Univ Picardie, INSERM U1088, Amiens, France
[3] Jules Verne Univ Picardie, EA4294, Amiens, France
[4] Beauvais Hosp, Dept Digest Surg, Beauvais, France
[5] Rouen Univ Hosp, Dept Digest Surg, Rouen, France
关键词
GLUTATHIONE-S-TRANSFERASE; INTESTINAL-OBSTRUCTION; RISK-FACTORS; ISCHEMIA; OPERATION; DIAGNOSIS; SEPSIS; MARKER;
D O I
10.1016/j.jamcollsurg.2012.12.051
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: Ischemia and necrosis are complications of small bowel obstruction (SBO) and require rapid surgical treatment. At present, there are no sufficiently accurate preoperative biomarkers of ischemia or necrosis. The objective of the current study was to evaluate the value of serum procalcitonin levels for predicting conservative management failure and the presence of intraoperatively observed bowel ischemia (reversible or not) in patients with SBO. STUDY DESIGN: One hundred and sixty-six participants of 242 in a randomized controlled trial focusing on the management of SBO (Acute Bowel Obstruction Diagnostic study [ABOD], NCT00389116) had available data on procalcitonin and were included in the study. The primary study objective was to determine whether serum procalcitonin could identify patients in whom conservative management (CM) failed (the surgical management [SM] group) and the subset of SM patients with intraoperatively observed ischemia (reversible or not). For the analysis, the patients were divided into subgroups according to the success or failure of CM and (for surgically managed patients) the presence or absence of intraoperative ischemia (reversible or not). RESULTS: Procalcitonin levels were higher in the SM group (n = 35) than in the CM group (n = 131) (0.53 vs 0.14 ng/mL; p = 0.031) and higher in the group managed surgically with ischemia (n = 12) than patients managed surgically without intraoperative ischemia (n = 23) (1.16 vs 0.21 ng/mL, respectively; p < 0.001). A multiple logistic regression showed that procalcitonin is a risk factor for CM failure (odds ratio = 3.5; 95% CI, 1.4-8.5; p = 0.006) and for ischemia (reversible or not) (odds ratio = 46.9; 95% CI, 4.0-547.3; p < 0.001). CONCLUSIONS: Procalcitonin can help predict CM failure and occurrence of bowel ischemia (reversible or not) in SBO patients, but additional studies are needed. ((c) 2013 by the American College of Surgeons)
引用
收藏
页码:997 / 1004
页数:8
相关论文
共 50 条
  • [1] CONSERVATIVE MANAGEMENT OF SMALL BOWEL OBSTRUCTION
    HELMKAMP, BF
    KIMMEL, J
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1985, 152 (06) : 677 - 679
  • [2] Laparoscopic management of acute small bowel obstruction: Evaluating the need for resection
    Johnson, Kevin N.
    Chapital, Alyssa B.
    Harold, Kristi L.
    Merritt, Marianne V.
    Johnson, Daniel J.
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2012, 72 (01): : 25 - 30
  • [3] Early operation or conservative management of patients with small bowel obstruction?
    Fevang, BT
    Jensen, D
    Svanes, K
    Viste, A
    EUROPEAN JOURNAL OF SURGERY, 2002, 168 (8-9) : 475 - 481
  • [4] Development of a simple model for predicting need for surgery in patients who initially undergo conservative management for adhesive small bowel obstruction
    Komatsu, Issei
    Tokuda, Yasuharu
    Shimada, Gen
    Jacobs, Joshua L.
    Onodera, Hisashi
    AMERICAN JOURNAL OF SURGERY, 2010, 200 (02): : 215 - 223
  • [5] Laparoscopic management of acute small bowel obstruction: Evaluating the need for resection DISCUSSION
    Peitzman, Andrew B.
    Hoff, William S.
    Mullins, Richard
    Mangram, Alicia
    Collins, Jay N.
    Shapiro, Brian S.
    Johnson, Kevin N.
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2012, 72 (01): : 30 - 31
  • [6] OUTCOME OF CONSERVATIVE MANAGEMENT OF ADHESIVE SMALL BOWEL OBSTRUCTION
    Hussain, Mohammad
    Ali, Nisar
    Israr, Mohammad
    Ismail, Mohammad
    Naeem, Syed Mohammad
    Ali, Manzoor
    GOMAL JOURNAL OF MEDICAL SCIENCES, 2012, 10 (01): : 141 - 143
  • [7] Conservative Management of Small Bowel Obstruction: A Local Experience
    Gonzalez, M.
    Aker, M.
    Manjunath, P.
    Mishra, A.
    Ward, N.
    BRITISH JOURNAL OF SURGERY, 2021, 108
  • [8] Point -of -care procalcitonin may predict the need for surgical treatment in patients with small bowel obstruction
    Murasaki, Misaki
    Nakanishi, Taizo
    Kano, Ken-ichi
    Shigemi, Ryo
    Tanizaki, Shinsuke
    Kono, Kumiko
    Hayashi, Minoru
    Nagai, Hideya
    Maeda, Shigenobu
    Ishida, Hiroshi
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2020, 38 (05): : 979 - 982
  • [9] Predictive value of procalcitonin for the need of surgery and the presence of ischemia and necrosis in patients with small bowel obstruction
    Evaristo-Mendez, Gerardo
    Gallegos-Sierra, Cuauhtly
    De La Cruz-Temores, Salvador
    CIRUGIA Y CIRUJANOS, 2019, 87 (01): : 45 - 52
  • [10] Usefulness of procalcitonin to assess the need for surgery and the presence of ischemia and necrosis in patients with small bowel obstruction
    Godinez-Vidal, Ansony R.
    Hernandez-Rodriguez, Guillermo E.
    Lopez-Romero, Sandra C.
    CIRUGIA Y CIRUJANOS, 2020, 88 (04): : 535 - 536